Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
NCT ID: NCT06050057
Last Updated: 2023-09-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2023-09-03
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. to find the superiority of one the the surgical method mentioned above
2. to compare the quality of life in patients with adrenal mass before surgery and after laparoscopic or robotic-assisted adrenalectomy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy
NCT01676025
Quality of Life and High-Risk Abdominal Cancer Surgery
NCT04444544
National Multicenter Cohort Study of Robot-Assisted Gastrectomy Versus Laparoscopy in Gastric Cancer
NCT06242613
Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol in Gastric Surgery for Cancer
NCT03865810
Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
NCT00002575
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written consent to participate in the study.
Exclusion Criteria
* Adrenal expansion \> 12 cm.
* Suspected malignant adrenal tumor with infiltrative growth or tumor venous thrombus according to imaging examination.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Ostrava
OTHER
Tomas Bata Hospital, Czech Republic
OTHER
General University Hospital, Prague
OTHER
University Hospital Hradec Kralove
OTHER
University Hospital Olomouc
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Natalia Wiesner
Head of the urological clinic, MUDr. Igor Hartmann Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MUDr. Igor Hartmann Ph.D.
Role: STUDY_CHAIR
Dpt. of Urology, University hospital Olomouc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University hospital Olomouc
Olomouc, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FNOL 122/23
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.